Moreover, higher expression of FAM83H is associated with an increased recurrence rate of prostatic cancer patients and shorter survival of uterine cancer [8], hepatocellular carcinoma [4], and clear cell renal cell carcinoma patients [11]. Here, SACK1H is linked to uterine cancer.